Analysis of the Effect of Demographic Variables on Lysosomal Enzyme Activities in the Missouri Newborn Screening Program
Newborn screening laboratories are increasingly adding lysosomal storage disorders (LSDs), such as Mucopolysaccharidosis I (MPS I) and Pompe disease, to their screening panels. Without newborn screening, LSDs are frequently diagnosed only after the onset of symptoms; late detection can lead to profo...
Saved in:
| Main Authors: | Lacey Vermette, Jon Washburn, Tracy Klug |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Series: | International Journal of Neonatal Screening |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2409-515X/11/2/48 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characterization of Dried Blood Spot Quality Control Materials for Lysosomal Enzyme Activity Assays Using Digital Microfluidic Fluorometry to Detect Lysosomal Storage Disorders in Newborns
by: Paul Dantonio, et al.
Published: (2025-06-01) -
Japanese experience of newborn screening for lysosomal storage diseases and adrenoleukodystrophy
by: Takanori Onuki, et al.
Published: (2025-07-01) -
The rapidly evolving view of lysosomal storage diseases
by: Giancarlo Parenti, et al.
Published: (2021-01-01) -
Effect of newborn genomic screening for lysosomal storage disorders: a cohort study in China
by: Xin Wang, et al.
Published: (2025-05-01) -
Impairment of chaperone‐mediated autophagy leads to selective lysosomal degradation defects in the lysosomal storage disease cystinosis
by: Gennaro Napolitano, et al.
Published: (2015-01-01)